Nurix Therapeutics (NasdaqGM:NRIX) Update / Briefing October 22, 2025 08:00 AM ET Company ParticipantsNone - Video NarratorPaula O’Connor - Chief Medical OfficerMatt Biegler - Managing DirectorArthur Sands - CEO and PresidentHans van Houte - CFOGwenn Hansen - Chief Scientific OfficerConference Call ParticipantsJeet Mukherjee - VP and Biotechnology AnalystNone - AnalystBrian Skorney - Senior Research Analyst of BiotechnologyBrian Abrahams - Biotechnology Equity Research AnalystSudan Loganathan - Managing Dir ...